Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5690682 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
In this ancillary data study, TSIC was not associated with improved OS in patients with stage III epithelial ovarian cancer. TSIC was significantly associated with PFS for the entire cohort, suggesting increase in PFS with longer TSIC. However, this was not found when only data from GOG 172 or GOG 114 were analyzed separately. Hence, the relationship between IP chemotherapy initiation and time from surgery needs to be studied further.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Arlene E MD, James J PhD, Wilberto MD, J Matthew MD, David E. MD, Shashikant B MD, Krishnansu S MD, Joan L MD, Angeles MD, Deborah K MD, Larry J MD,